Pliant Therapeutics, Inc. 9PT.MU Stock
Pliant Therapeutics, Inc. Price Chart
Pliant Therapeutics, Inc. 9PT.MU Financial and Trading Overview
| Pliant Therapeutics, Inc. stock price | 13.4 EUR |
| Previous Close | 22.4 EUR |
| Open | 21.4 EUR |
| Bid | 21.2 EUR x N/A |
| Ask | 21.4 EUR x N/A |
| Day's Range | 21.4 - 21.4 EUR |
| 52 Week Range | 6.55 - 33 EUR |
| Volume | 410 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.31B EUR |
| Beta (5Y Monthly) | 1.403225 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.56 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9PT.MU Valuation Measures
| Enterprise Value | 1.33B EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 134.06767 |
| Price/Book (mrq) | 2.2462473 |
| Enterprise Value/Revenue | 136.249 |
| Enterprise Value/EBITDA | -9.557 |
Trading Information
Pliant Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.403225 |
| 52-Week Change | 232.82% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 33 EUR |
| 52 Week Low | 6.55 EUR |
| 50-Day Moving Average | 22.58 EUR |
| 200-Day Moving Average | 22.98 EUR |
9PT.MU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 59.16M |
| Float | 45.16M |
| Short Ratio | N/A |
| % Held by Insiders | 6.67% |
| % Held by Institutions | 79.01% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1444.34% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.18% |
| Return on Equity (ttm) | -36.092% |
Income Statement
| Revenue (ttm) | 9.77M EUR |
| Revenue Per Share (ttm) | 0.21 EUR |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 9.69M EUR |
| EBITDA | -139264000 EUR |
| Net Income Avi to Common (ttm) | -132769000 EUR |
| Diluted EPS (ttm) | -2.7 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 577.31M EUR |
| Total Cash Per Share (mrq) | 9.76 EUR |
| Total Debt (mrq) | 15.19M EUR |
| Total Debt/Equity (mrq) | 2.7 EUR |
| Current Ratio (mrq) | 25.406 |
| Book Value Per Share (mrq) | 9.527 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -104409000 EUR |
| Levered Free Cash Flow (ttm) | -56702248 EUR |
Profile of Pliant Therapeutics, Inc.
| Country | Germany |
| State | CA |
| City | South San Francisco |
| Address | 260 Littlefield Avenue |
| ZIP | 94080 |
| Phone | 650 481 6770 |
| Website | https://pliantrx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 136 |
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase IIa trials for idiopathic pulmonary fibrosis and primary sclerosing cholangitis. It also develops PLN-1474, a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Q&A For Pliant Therapeutics, Inc. Stock
What is a current 9PT.MU stock price?
Pliant Therapeutics, Inc. 9PT.MU stock price today per share is 13.4 EUR.
How to purchase Pliant Therapeutics, Inc. stock?
You can buy 9PT.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pliant Therapeutics, Inc.?
The stock symbol or ticker of Pliant Therapeutics, Inc. is 9PT.MU.
Which industry does the Pliant Therapeutics, Inc. company belong to?
The Pliant Therapeutics, Inc. industry is Biotechnology.
How many shares does Pliant Therapeutics, Inc. have in circulation?
The max supply of Pliant Therapeutics, Inc. shares is 60.24M.
What is Pliant Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Pliant Therapeutics, Inc. PE Ratio is now.
What was Pliant Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Pliant Therapeutics, Inc. EPS is -2.56 EUR over the trailing 12 months.
Which sector does the Pliant Therapeutics, Inc. company belong to?
The Pliant Therapeutics, Inc. sector is Healthcare.